Compounds > sdz wag-994
Page last updated: 2024-09-05

sdz wag-994 and Ventricular Dysfunction, Left

sdz wag-994 has been researched along with Ventricular Dysfunction, Left in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anand, IS; Bertolet, BD; Bryg, RJ; Chatterjee, K; Cohn, JN; Khurmi, NS; Mohanty, PK; Pepine, CJ1

Trials

1 trial(s) available for sdz wag-994 and Ventricular Dysfunction, Left

ArticleYear
Effects of A1 adenosine receptor agonism using N6-cyclohexyl-2'-O-methyladenosine in patients with left ventricular dysfunction.
    Circulation, 1996, Sep-15, Volume: 94, Issue:6

    Topics: Adenosine; Adult; Aged; Electrocardiography; Female; Hemodynamics; Hormones; Humans; Male; Middle Aged; Purinergic P1 Receptor Agonists; Receptors, Purinergic P1; Ventricular Dysfunction, Left

1996